Filing Details
- Accession Number:
- 0001225208-22-011463
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-11-08 17:24:14
- Reporting Period:
- 2022-11-04
- Accepted Time:
- 2022-11-08 17:24:14
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
874766 | Hartford Financial Services Group Inc. | HIG | Fire, Marine & Casualty Insurance (6331) | 133317783 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1349356 | Christopher Swift | One Hartford Plaza Hartford CT 06155 | Chairman And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-11-04 | 430 | $24.15 | 157,550 | No | 4 | M | Direct | |
Common Stock | Disposition | 2022-11-04 | 430 | $74.05 | 157,120 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2022-11-07 | 14,324 | $24.15 | 171,444 | No | 4 | M | Direct | |
Common Stock | Disposition | 2022-11-07 | 14,324 | $74.01 | 157,120 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option | Disposition | 2022-11-04 | 430 | $0.00 | 430 | $24.15 |
Common Stock | Stock Option | Disposition | 2022-11-07 | 14,324 | $0.00 | 14,324 | $24.15 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
80,343 | 2023-03-05 | No | 4 | M | Direct | |
66,019 | 2023-03-05 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 43,179 | Indirect | By Spouse |
Common Stock | 95,386 | Indirect | Swift Family Gift Trust |
Common Stock | 60,865 | Indirect | Swift Family Legacy Trust |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option | $35.83 | 2024-03-04 | 103,872 | 103,872 | Direct | |
Common Stock | Stock Option | $41.25 | 2025-03-03 | 301,887 | 301,887 | Direct | |
Common Stock | Stock Option | $43.59 | 2026-03-01 | 294,481 | 294,481 | Direct | |
Common Stock | Stock Option | $48.89 | 2027-02-28 | 302,908 | 302,908 | Direct | |
Common Stock | Stock Option | $49.01 | 2029-02-26 | 352,263 | 352,263 | Direct | |
Common Stock | Stock Option | $51.87 | 2031-02-23 | 310,820 | 310,820 | Direct | |
Common Stock | Stock Option | $53.81 | 2028-02-27 | 284,819 | 284,819 | Direct | |
Common Stock | Stock Option | $55.27 | 2030-02-25 | 327,679 | 327,679 | Direct | |
Common Stock | Stock Option | $69.41 | 2032-02-23 | 301,932 | 301,932 | Direct |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
2024-03-04 | 103,872 | 103,872 | Direct |
2025-03-03 | 301,887 | 301,887 | Direct |
2026-03-01 | 294,481 | 294,481 | Direct |
2027-02-28 | 302,908 | 302,908 | Direct |
2029-02-26 | 352,263 | 352,263 | Direct |
2031-02-23 | 310,820 | 310,820 | Direct |
2028-02-27 | 284,819 | 284,819 | Direct |
2030-02-25 | 327,679 | 327,679 | Direct |
2032-02-23 | 301,932 | 301,932 | Direct |
Footnotes
- The transaction reported on this Form 4 was effected pursuant to a trading plan previously adopted by Mr. Swift on March 15, 2022, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The exercised options were granted to Mr. Swift in 2013 and scheduled to expire on March 5, 2023.
- Price reflected is the weighted average sale price for shares sold. The range of sales prices for the transactions reported was $74.00 - $74.08 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- Price reflected is the weighted average sale price for shares sold. The range of sales prices for the transactions reported was $74.00 - $74.19 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The options became fully exercisable on March 5, 2016, the third anniversary of the grant date.
- The options became fully exercisable on March 4, 2017, the third anniversary of the grant date.
- The options became fully exercisable on March 3, 2018, the third anniversary of the grant date.
- The options became fully exercisable on March 1, 2019, the third anniversary of the grant date.
- The options became fully exercisable on February 28, 2020, the third anniversary of the grant date.
- The options became fully exercisable on February 26, 2022, the third anniversary of the grant date.
- One-third of the options became exercisable on February 23, 2022, an additional one-third of the options will become exercisable on February 23, 2023 and the remaining one-third of the options will become exercisable on February 23, 2024, the third anniversary of the grant date.
- The options became fully exercisable on February 27, 2021, the third anniversary of the grant date.
- One-third of the options became exercisable on February 25, 2021, an additional one-third of the options became exercisable on February 25, 2022 and the remaining one-third of the options will become exercisable on February 25, 2023, the third anniversary of the grant date.
- One-third of the options will become exercisable on February 23, 2023, an additional one-third of the options will become exercisable on February 23, 2024 and the remaining one-third of the options will become exercisable on February 23, 2025, the third anniversary of the grant date.